Medical Countermeasures Needle-Free Influenza Vaccines: HKUMed Advances New Live-Attenuated Platforms with Cross-Subtype PotentialGlobal Biodefense StaffMay 9, 2025
Medical Countermeasures Repositioning Smallpox Vaccines for a New Threat: MpoxGlobal Biodefense StaffMay 8, 2025
Medical Countermeasures New Monoclonal Antibodies Offer Hope for Universal Influenza TreatmentGlobal Biodefense StaffMay 1, 2025
RedHill Biopharma Highlights Federal Medical Countermeasure Investments Industry News August 17, 2023 …
Treatments for Poxviruses May Already Exist in Licensed Drugs Medical Countermeasures August 9, 2023 …
U.S. Invests in mAb Treatment for Ebola with New Award to Emergent BioSolutions Industry News July 31, 2023 …
After Missing the Mark in COVID Trial, Revive Therapeutics Pursues Bucillamine as CBRN Medical Countermeasure Industry News July 28, 2023 …
Smallpox Countermeasures: U.S. Awards $138M to Siga Technologies for TPOXX Industry News July 27, 2023 …
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine Medical Countermeasures July 20, 2023 …
VitriVax Wins DoD Contract to Develop Single-Shot Vaccine for Melioidosis and Glanders Industry News July 19, 2023 …
DARPA Award to Ginkgo Bioworks Aims to Revolutionize Speed of Medical Countermeasure Manufacturing Industry News July 19, 2023 …
NIAID Awards Multiple Contracts for Radiation Medical Countermeasures and Biodosimetry CBRNE July 9, 2023 …
Revive Therapeutics Announces Results of Phase 3 Study for Bucillamine in the Treatment of COVID-19 Industry News July 6, 2023 …
UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness Contracts + Grants May 26, 2023 …
A-Alpha Bio and Lawrence Livermore to Accelerate Antibody Discovery and Development for Biothreats Industry News May 16, 2023 …
DARPA Selects Teams to Develop Vaccine Durability Prediction Model Medical Countermeasures January 13, 2023 …
Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding Industry News January 12, 2023 …
